US Bancorp
HTGM

US Bancorp’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

US Bancorp’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9
Closed -$5K – 3652
2016
Q2 		$5K Hold
9
– – ﹤0.01% 3205
2016
Q1 		$5K Hold
9
– – ﹤0.01% 3185
2015
Q4 		$7K Buy
+9
New +$8.85K ﹤0.01% 3152

Other funds holding HTGM

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

US Bancorp's HTGM Position: Q3 2016 in Review

US Bancorp sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2016, closing a stake of 9 shares — an estimated $5K sold.

US Bancorp first reported a position in HTGM in Q4 2015 and held it in 3 quarters. The position peaked at $7K in Q4 2015. 22 funds tracked by Wall St. Rank hold HTGM as of Q3 2016.

  • US Bancorp reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • US Bancorp sold 9 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2016, an estimated $5K.
  • US Bancorp first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q4 2015 and held it in 3 quarters.
  • US Bancorp's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $7K in Q4 2015.
  • 22 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2016.

Based on US Bancorp's 13F filing for Q3 2016, filed 4 Nov 2016.